As the state legislative session comes to a close, we often focus on the things the Legislature should be doing.
On the whole, New Yorkers can breathe a sigh of relief if the state Senate’s gridlock forces an early end to the 2018 regular session of the Legislature. Otherwise, the next two weeks will still leave plenty of time for lawmakers to get up to no good.
As a 19th-century Manhattan politician once observed, “no man’s life, liberty or property are safe while the Legislature is in session.” Some things never change. On balance, New Yorkers would probably be better off if this year’s legislative session ended ahead of its scheduled June 21 adjournment.
Existing state regulations, along with competitive pressures, assure that health insurers will share much if not all of the benefit of federal tax cuts with their policyholders. Rather than trying to grab the money or dictate how it's spent, lawmakers should let market forces do their work.
With the state facing its grimmest budget outlook in years, the legislative session shows signs of becoming a tug-of-war between public schools and health care—the two biggest recipients of state spending and, not coincidentally, the two heaviest-hitting lobbying forces Albany.
This report provides an overview of the current landscape of union representation, finances, lobbying and political activity in New York State. It concludes with recommendations designed to strengthen the rights of government workers and the oversight of union nances that are ultimately derived from taxpayer-funded salaries.
The makers of the anti-addiction drug Vivitrol – whose controversial nationwide lobbying campaign was spotlighted by the New York Times last week – appear to be getting results in Albany.
State legislators have taken their mania for insurance mandates to a new extreme: They’ve passed a bill that arguably accomplishes nothing other than covering unnecessary mammograms.